Thursday, 24 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Company
Deals
XJTLU and University of Liverpool Launch Joint Centre for Pharmacology and Therapeutics
January 29, 2025
Company
Deals
Yifan Pharmaceutical Licenses F-627 to Acrotech for US Distribution
January 29, 2025
Company
Deals
Nans Tech Secures Series A Funding for Brain Dysfunction Digital Therapies
January 30, 2025
Company
Deals
Aclaris Therapeutics Licenses JAK Inhibitor ATI-1777 to Pediatrix for Greater China
January 29, 2025
Policy / Regulatory
China’s NMPA Issues New GSP Appendix for Drug Retailing Quality Management
January 30, 2025
Company
Drug
ImmuneOnco Initiates Phase II Clinical Study for CD47 Antibody IMM01
January 30, 2025
Policy / Regulatory
China’s NMPA Seeks Feedback on Drug Quality Management Provisions
January 30, 2025
Company
Deals
Luye Pharma’s Shandong Boan Bio Files for Hong Kong IPO
January 30, 2025
Company
Deals
Luca Healthcare Partners with Cambridge Cognition to Launch Cognitive Tools in China
January 30, 2025
Company
Drug
Luye Pharma’s Biosimilar to Amgen’s Xgeva Launched in China
January 30, 2025
Company
Medical Device
Assure Tech Wins Japanese PDMA Approval for Pen-Type COVID-19 Antigen Test
January 30, 2025
Company
Drug
Double-Crane Pharma Gains NMPA Approval for COVID-19 Drug CX2101A Clinical Trials
February 12, 2025
1
2
…
1,084
1,085
1,086
1,087
1,088
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?